"Same company, board and management, same asset base, same pristine financial performance.... the only thing different today is the fact that the valuation multiple has nearly doubled"
Valuation multiple has nearly doubled as the blood of America's most poor and vulnerable has become more and more tastier to CSL's and its insatiable Renfield syndrome.
Blood supply shortage in the US, page-60
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$295.56 |
Change
-4.190(1.40%) |
Mkt cap ! $142.8B | |||
| Open | High | Low | Value | Volume |
| $299.64 | $300.03 | $294.81 | $174.3M | 587.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2500 | $295.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $295.56 | 688 | 2 |
View Market Depth
| Last trade - 16.10pm 08/07/2024 (20 minute delay) ? |
| CSL (ASX) Chart |